Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types

Molecular Oncology

Volumn 9, Issue 4, 2015, Pages 783-790

  Lebofsky, Ronald ^a   Decraene, Charles ^a,b   Bernard, Virginie ^a   Kamal, Maud ^a   Blin, Anthony ^a   Leroy, Quentin ^a   Rio Frio, Thomas ^a   Pierron, Gaëlle ^a   Callens, Céline ^a   Bieche, Ivan ^a   Saliou, Adrien ^a   Madic, Jordan ^a   Rouleau, Etienne ^a   Bidard, François Clément ^a   Lantz, Olivier ^a,c   Stern, Marc Henri ^d   Le Tourneau, Christophe ^a,e   Pierga, Jean Yves ^a,f  

^a INSTITUT CURIE   (France)

^b INSTITUT CURIE   (France)

^c PSL RESEARCH UNIVERSITY   (France)

^d INSTITUT CURIE   (France)

^e INSERM U900   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Circulating tumor DNA; Liquid biopsy; Multiple tumor types; Next generation sequencing; SHIVA trial

Indexed keywords

CHLOROPLAST DNA; DNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; DNA EXTRACTION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN TISSUE; LENGTH OF STAY; MALE; MIDDLE AGED; NEXT GENERATION SEQUENCING; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOLID TUMOR; SOMATIC MUTATION; TISSUE SECTION; TUMOR BIOPSY; TUMOR SUPPRESSOR GENE; VERY ELDERLY; BIOPSY; BLOOD; GENETICS; GENOTYPING TECHNIQUE; METABOLISM; METASTASIS; MUTATION; NEOPLASM; PATHOLOGY; TUMOR EMBOLISM;

AGED; AGED, 80 AND OVER; BIOPSY; DNA, NEOPLASM; FEMALE; GENE FREQUENCY; GENOTYPING TECHNIQUES; HUMANS; MIDDLE AGED; MUTATION; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; PRECISION MEDICINE;

EID: 84926416450     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2014.12.003     Document Type: Article

References (22)

1. Andre F., Bachelot T., Commo F., Campone M., Arnedos M., Dieras V., Lacroix-Triki M., Lacroix L., Cohen P., Gentien D., Adelaide J., Dalenc F., Goncalves A., Levy C., Ferrero J.M., Bonneterre J., Lefeuvre C., Jimenez M., Filleron T., Bonnefoi H. Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER). Lancet Oncol. 2014, 15:267-274.
2. Arnedos M., Vielh P., Soria J.C., Andre F. The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?. J.Pathol. 2014, 232:274-282.
3. Bettegowda C., Sausen M., Leary R.J., Kinde I., Wang Y., Agrawal N., Bartlett B.R., Wang H., Luber B., Alani R.M., Antonarakis E.S., Azad N.S., Bardelli A., Brem H., Cameron J.L., Lee C.C., Fecher L.A., Gallia G.L., Gibbs P., Le D., Giuntoli R.L., Goggins M., Hogarty M.D., Holdhoff M., Hong S.M., Jiao Y., Juhl H.H., Kim J.J., Siravegna G., Laheru D.A., Lauricella C., Lim M., Lipson E.J., Marie S.K., Netto G.J., Oliner K.S., Olivi A., Olsson L., Riggins G.J., Sartore-Bianchi A., Schmidt K., Shih l M., Oba-Shinjo S.M., Siena S., Theodorescu D., Tie J., Harkins T.T., Veronese S., Wang T.L., Weingart J.D., Wolfgang C.L., Wood L.D., Xing D., Hruban R.H., Wu J., Allen P.J., Schmidt C.M., Choti M.A., Velculescu V.E., Kinzler K.W., Vogelstein B., Papadopoulos N., Diaz L.A. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci. Transl. Med. 2014, 6:224ra224.
4. Bidard F.C., Weigelt B., Reis-Filho J.S. Going with the flow: from circulating tumor cells to DNA. Sci. Transl. Med. 2013, 5:207ps214.
5. Couraud S., Vaca Paniagua F., Villar S., Oliver J., Schuster T., Blanche H., Girard N., Tredaniel J., Guilleminault L., Gervais R., Prim N., Vincent M., Margery J., Larive S., Foucher P., Duvert B., Vallee M., Le Calvez-Kelm F., McKay J., Missy P., Morin F., Zalcman G., Olivier M., Souquet P.J. Non-invasive diagnosis of actionable mutations by deep sequencing of circulating-free DNA in non-small cell lung cancer: findings from BioCAST/IFCT-1002. Clin. Cancer Res. 2014, 10.1158/1078-0432.CCR-13-3063.
6. Criscitiello C., Andre F., Thompson A.M., De Laurentiis M., Esposito A., Gelao L., Fumagalli L., Locatelli M., Minchella I., Orsi F., Goldhirsch A., Curigliano G. Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives. Breast Cancer Res. 2014, 16:205.
7. Crowley E., Di Nicolantonio F., Loupakis F., Bardelli A. Liquid biopsy: monitoring cancer-genetics in the blood. Nat. Rev. Clin. Oncol. 2013, 10:472-484.
8. Dawson S.J., Tsui D.W., Murtaza M., Biggs H., Rueda O.M., Chin S.F., Dunning M.J., Gale D., Forshew T., Mahler-Araujo B., Rajan S., Humphray S., Becq J., Halsall D., Wallis M., Bentley D., Caldas C., Rosenfeld N. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N.Engl. J. Med. 2013, 368:1199-1209.
9. Diaz L.A., Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. J.Clin. Oncol. 2014, 32:579-586.
10. Diehl F., Schmidt K., Choti M.A., Romans K., Goodman S., Li M., Thornton K., Agrawal N., Sokoll L., Szabo S.A., Kinzler K.W., Vogelstein B., Diaz L.A. Circulating mutant DNA to assess tumor dynamics. Nat. Med. 2008, 14:985-990.
11. Forshew T., Murtaza M., Parkinson C., Gale D., Tsui D.W., Kaper F., Dawson S.J., Piskorz A.M., Jimenez-Linan M., Bentley D., Hadfield J., May A.P., Caldas C., Brenton J.D., Rosenfeld N. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med. 2012, 4:136ra168.
12. Gerlinger M., Horswell S., Larkin J., Rowan A.J., Salm M.P., Varela I., Fisher R., McGranahan N., Matthews N., Santos C.R., Martinez P., Phillimore B., Begum S., Rabinowitz A., Spencer-Dene B., Gulati S., Bates P.A., Stamp G., Pickering L., Gore M., Nicol D.L., Hazell S., Futreal P.A., Stewart A., Swanton C. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat. Genet. 2014, 46:225-233.
13. Le Tourneau C., Paoletti X., Servant N., Bieche I., Gentien D., Rio Frio T., Vincent-Salomon A., Servois V., Romejon J., Mariani O., Bernard V., Huppe P., Pierron G., Mulot F., Callens C., Wong J., Mauborgne C., Rouleau E., Reyes C., Henry E., Leroy Q., Gestraud P., La Rosa P., Escalup L., Mitry E., Tredan O., Delord J.P., Campone M., Goncalves A., Isambert N., Gavoille C., Kamal M. Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial. Br. J. Cancer 2014, 111:17-24.
14. Madic J., Piperno-Neumann S., Servois V., Rampanou A., Milder M., Trouiller B., Gentien D., Saada S., Assayag F., Thuleau A., Nemati F., Decaudin D., Bidard F.C., Desjardins L., Mariani P., Lantz O., Stern M.H. Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma. Clin. Cancer Res. 2012, 18:3934-3941.
15. Madic J., Kiialainen A., Bidard F.C., Birzele F., Ramey G., Leroy Q., Rio Frio T., Vaucher I., Raynal V., Bernard V., Lermine A., Clausen I., Giroud N., Schmucki R., Milder M., Horn C., Spleiss O., Lantz O., Stern M.H., Pierga J.Y., Weisser M., Lebofsky R. Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients. Int. J. Cancer 2014, [Epub ahead of print]. 10.1002/ijc.29265.
16. Murtaza M., Dawson S.J., Tsui D.W., Gale D., Forshew T., Piskorz A.M., Parkinson C., Chin S.F., Kingsbury Z., Wong A.S., Marass F., Humphray S., Hadfield J., Bentley D., Chin T.M., Brenton J.D., Caldas C., Rosenfeld N. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 2013, 497:108-112.
17. Newman A.M., Bratman S.V., To J., Wynne J.F., Eclov N.C., Modlin L.A., Liu C.L., Neal J.W., Wakelee H.A., Merritt R.E., Shrager J.B., Loo B.W., Alizadeh A.A., Diehn M. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat. Med. 2014, 20:548-554.
18. Schwarzenbach H., Hoon D.S., Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer 2011, 11:426-437.
19. Servant N., Romejon J., Gestraud P., La Rosa P., Lucotte G., Lair S., Bernard V., Zeitouni B., Coffin F., Jules-Clement G., Yvon F., Lermine A., Poullet P., Liva S., Pook S., Popova T., Barette C., Prud'homme F., Dick J.G., Kamal M., Le Tourneau C., Barillot E., Hupe P. Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial. Front Genet. 2014, 5:152.
20. Tarabeux J., Zeitouni B., Moncoutier V., Tenreiro H., Abidallah K., Lair S., Legoix-Ne P., Leroy Q., Rouleau E., Golmard L., Barillot E., Stern M.H., Rio-Frio T., Stoppa-Lyonnet D., Houdayer C. Streamlined ion torrent PGM-based diagnostics: BRCA1 and BRCA2 genes as a model. Eur. J. Hum. Genet. 2014, 22:535-541.
21. Thierry A.R., Mouliere F., El Messaoudi S., Mollevi C., Lopez-Crapez E., Rolet F., Gillet B., Gongora C., Dechelotte P., Robert B., Del Rio M., Lamy P.J., Bibeau F., Nouaille M., Loriot V., Jarrousse A.S., Molina F., Mathonnet M., Pezet D., Ychou M. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Nat. Med. 2014, 20:430-435.
22. Thorvaldsdottir H., Robinson J.T., Mesirov J.P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013, 14:178-192.